KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ginkgo Bioworks Holdings (DNA) Equity Average (2020 - 2025)

Ginkgo Bioworks Holdings filings provide 6 years of Equity Average readings, the most recent being $534.2 million for Q4 2025.

  • On a quarterly basis, Equity Average fell 29.43% to $534.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $534.2 million, a 29.43% decrease, with the full-year FY2025 number at $612.3 million, down 32.46% from a year prior.
  • Equity Average hit $534.2 million in Q4 2025 for Ginkgo Bioworks Holdings, down from $586.4 million in the prior quarter.
  • In the past five years, Equity Average ranged from a high of $1.7 billion in Q1 2023 to a low of $375.7 million in Q2 2021.
  • Median Equity Average over the past 5 years was $1.0 billion (2021), compared with a mean of $1.1 billion.
  • Biggest five-year swings in Equity Average: skyrocketed 324.77% in 2022 and later tumbled 41.49% in 2024.
  • Ginkgo Bioworks Holdings' Equity Average stood at $1.6 billion in 2021, then decreased by 0.16% to $1.6 billion in 2022, then fell by 26.11% to $1.2 billion in 2023, then crashed by 35.57% to $757.0 million in 2024, then dropped by 29.43% to $534.2 million in 2025.
  • The last three reported values for Equity Average were $534.2 million (Q4 2025), $586.4 million (Q3 2025), and $630.2 million (Q2 2025) per Business Quant data.